Business · 23/07/2015Updated: 10/17/2026 · 1 min read
FDA Announces Draft Guidance for Gastroparesis Treatment
Summary
The Food and Drug Administration (FDA) has released a draft guidance document outlining its recommendations for clinical trials and endpoint assessments to support the development of new treatments for diabetic and idiopathic gastroparesis.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →